ETTX - Entasis Therapeutics Holdings Inc. (ETTX) CEO Manoussos Perros on Q3 2021 Results - Earnings Call Transcript
Entasis Therapeutics Holdings Inc. (ETTX) Q3 2021 Earnings Conference Call November 3, 2021, 08:00 AM ET Company Participants Bruce Mackle - Managing Director, LifeSci Advisors Manoussos Perros - President and CEO Mike Gutch - CFO and Chief Business Officer David Altarac - Chief Medical Officer Conference Call Participants Carvey Leung - Cantor Fitzgerald James Molloy - Alliance Global Partners Thomas Yip - H.C. Wainwright & Co. Robert Driscoll - Wedbush Securities Presentation Operator Good day, and welcome to the Entasis Therapeutics Third Quarter 2021 Earnings Conference Call. Today's conference is being recorded. At this time, I will turn the call over to Bruce Mackle, Managing Director with LifeSci Advisors. Please go ahead, sir. Bruce Mackle Thank you, operator. Before we proceed with the call, I would like to remind everyone that certain statements made during this call are forward-looking statements under U.S. Federal Securities Laws. These statements are subject to
For further details see:
Entasis Therapeutics Holdings Inc. (ETTX) CEO Manoussos Perros on Q3 2021 Results - Earnings Call Transcript